Legend Biotech (LEGN) Interest Expenses (2019 - 2025)
Legend Biotech (LEGN) posted Interest Expenses of -$5.5 million for Q4 2025, up 2.41% on a QoQ basis from -$5.6 million in Q3 2025, and down 5.77% year-over-year from -$5.8 million in Q4 2024.
Legend Biotech (LEGN) Interest Expenses (2019 - 2025) Analysis & Trends
Legend Biotech's Interest Expenses history runs 7 years deep, the most recent figure standing at -$5.5 million for Q4 2025.
- Quarterly Interest Expenses fell 5.77% year-over-year to -$5.5 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$21.4 million (up 1.13% YoY) and the FY2025 annual result came in at -$21.4 million, down 199.01% from the prior year.
- Interest Expenses was -$5.5 million for Q4 2025 at Legend Biotech, up from -$5.6 million in the prior quarter.
- Across five years, Interest Expenses topped out at $26.3 million in Q3 2023 and bottomed at -$8.6 million in Q3 2022.
- A 5-year average of -$1.4 million and a median of -$5.0 million in 2022 frame the typical range for Interest Expenses.
- Annual changes were most pronounced in 2022 — Interest Expenses jumped 4247.31% — and 2024, when it tumbled 89247.08%.
- Legend Biotech's Interest Expenses stood at -$602000.0 in 2021, then sank by 707.48% to -$4.9 million in 2022, then jumped by 99.88% to -$5820.0 in 2023, then tumbled by 89247.08% to -$5.2 million in 2024, then slipped by 5.77% to -$5.5 million in 2025.
- Business Quant data shows LEGN's Interest Expenses at -$5.5 million in Q4 2025, -$5.6 million in Q3 2025, and -$5.2 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -42,141.15 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 100,000.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 32.89 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 420.30 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 28.30 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 1.17 Bn |
| 10 | Legend Biotech | 8.26 Bn | 7.36 Bn | - | -5.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -5.50 Mn |
| Dec 31, 2025 | -5.50 Mn |
| Sep 30, 2025 | -5.64 Mn |
| Sep 30, 2025 | -5.64 Mn |
| Jun 30, 2025 | -5.22 Mn |
| Jun 30, 2025 | -5.22 Mn |
| Mar 31, 2025 | -5.06 Mn |
| Mar 31, 2025 | -5.06 Mn |
| Dec 31, 2024 | -5.20 Mn |
| Dec 31, 2024 | -5.20 Mn |
| Sep 30, 2024 | -5.50 Mn |
| Sep 30, 2024 | -5.50 Mn |
| Jun 30, 2024 | -5.48 Mn |
| Jun 30, 2024 | -5.48 Mn |
| Mar 31, 2024 | -5.48 Mn |
| Mar 31, 2024 | -5.48 Mn |
| Dec 31, 2023 | -5,820.00 |
| Dec 31, 2023 | -5,820.00 |
| Sep 30, 2023 | 26.27 Mn |
| Sep 30, 2023 | 26.27 Mn |